6-29941979-G-C

Variant names:

• chr6-29941979-G-C
• rs9260109
• ENST00000706892.1:n.9G>C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The ENST00000706892.1(HLA-A):​n.9G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.546 in 148,454 control chromosomes in the GnomAD database, including 21,061 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.55 (21061 hom., cov: 33)
  • Exomes 𝑓: 0.63 (2522 hom.)
  • Failed GnomAD Quality Control
• Consequence: HLA-A ENST00000706892.1 non_coding_transcript_exon
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.379
• Publications: 2 publications found

Genes affected

HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

POLR1HASP (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -8 ACMG points.

• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.586 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000706892.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
There are no transcript annotations for this variant.

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	HLA-A	ENST00000706892.1		n.9G>C		non_coding_transcript_exon	Exon 1 of 4
	HLA-A	ENST00000706893.1		n.-268G>C		non_coding_transcript_exon	Exon 1 of 9	ENSP00000516609.1
	HLA-A	ENST00000706895.1		n.9G>C		non_coding_transcript_exon	Exon 1 of 6

Frequencies

GnomAD3 genomes AF: 0.546 AC: 80926 AN: 148332 Hom.: 21013 Cov.: 33

Gnomad AFR AF: 0.592

Gnomad AMI AF: 0.491

Gnomad AMR AF: 0.589

Gnomad ASJ AF: 0.580

Gnomad EAS AF: 0.496

Gnomad SAS AF: 0.500

Gnomad FIN AF: 0.513

Gnomad MID AF: 0.526

Gnomad NFE AF: 0.518

Gnomad OTH AF: 0.554

GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.627 AC: 7475 AN: 11926 Hom.: 2522 Cov.: 0 AF XY: 0.646 AC XY: 4342 AN XY: 6724

African (AFR) AF: 0.552 AC: 139 AN: 252

American (AMR) AF: 0.746 AC: 264 AN: 354

Ashkenazi Jewish (ASJ) AF: 0.589 AC: 258 AN: 438

East Asian (EAS) AF: 0.587 AC: 420 AN: 716

South Asian (SAS) AF: 0.733 AC: 2046 AN: 2792

European-Finnish (FIN) AF: 0.692 AC: 155 AN: 224

Middle Eastern (MID) AF: 0.511 AC: 46 AN: 90

European-Non Finnish (NFE) AF: 0.585 AC: 3720 AN: 6356

Other (OTH) AF: 0.607 AC: 427 AN: 704

GnomAD4 genome AF: 0.546 AC: 81025 AN: 148454 Hom.: 21061 Cov.: 33 AF XY: 0.544 AC XY: 39451 AN XY: 72476

African (AFR) AF: 0.592 AC: 24041 AN: 40592

American (AMR) AF: 0.590 AC: 8865 AN: 15038

Ashkenazi Jewish (ASJ) AF: 0.580 AC: 1981 AN: 3416

East Asian (EAS) AF: 0.496 AC: 2458 AN: 4952

South Asian (SAS) AF: 0.502 AC: 2271 AN: 4528

European-Finnish (FIN) AF: 0.513 AC: 5354 AN: 10444

Middle Eastern (MID) AF: 0.528 AC: 152 AN: 288

European-Non Finnish (NFE) AF: 0.518 AC: 34341 AN: 66260

Other (OTH) AF: 0.550 AC: 1125 AN: 2046

Alfa AF: 0.404 Hom.: 620

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.84
CADD	Benign	0.59
DANN	Benign	0.59
PhyloP100		-0.38
PromoterAI		-0.074	Neutral
Mutation Taster		=300/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.28		Details are displayed if max score is > 0.2
DS_AL_spliceai		0.28		Position offset: -13

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs9260109; hg19: chr6-29909756;